Clinical Interest of the Combined Use of Serum CD26 and Alpha-L-Fucosidase in the Early Diagnosis of Colorectal Cancer

The purpose of this study was to assess if the combination of CD26 and alpha-L-fucosidase has a role in the diagnosis of colorectal cancer, paying particular attention to the stages in which the tumour is not yet disseminated. CD26 concentration and alpha-L-fucosidase activity were determined in ser...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayude, Daniel, de la Cadena, María Páez, Cordero, Oscar Javier, Nogueira, Montserrat, Ayude, José, Fernández-Briera, Almudena, Rodríguez-Berrocal, Francisco Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2004
Materias:
Other
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851403/
https://www.ncbi.nlm.nih.gov/pubmed/15258327
http://dx.doi.org/10.1155/2004/834309
_version_ 1782294276161404928
author Ayude, Daniel
de la Cadena, María Páez
Cordero, Oscar Javier
Nogueira, Montserrat
Ayude, José
Fernández-Briera, Almudena
Rodríguez-Berrocal, Francisco Javier
author_facet Ayude, Daniel
de la Cadena, María Páez
Cordero, Oscar Javier
Nogueira, Montserrat
Ayude, José
Fernández-Briera, Almudena
Rodríguez-Berrocal, Francisco Javier
author_sort Ayude, Daniel
collection PubMed
description The purpose of this study was to assess if the combination of CD26 and alpha-L-fucosidase has a role in the diagnosis of colorectal cancer, paying particular attention to the stages in which the tumour is not yet disseminated. CD26 concentration and alpha-L-fucosidase activity were determined in sera from 110 colorectal cancer patients and 46 donors. The combination of CD26 and alpha-L-fucosidase showed a specificity of 100% with a sensitivity of 64% in the diagnosis of colorectal cancer. Interestingly, the combination of both markers had a sensitivity of 75% in the stage I at the highest specificity (100%), providing also high sensitivity levels for the other non-disseminated stages (66% for stages II and III). In conclusion, the combined use of CD26 and alpha-L-fucosidase offers high sensitivity with high specificity in the diagnosis of colorectal cancer, especially at the earliest stage (TNM I).
format Online
Article
Text
id pubmed-3851403
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-38514032013-12-17 Clinical Interest of the Combined Use of Serum CD26 and Alpha-L-Fucosidase in the Early Diagnosis of Colorectal Cancer Ayude, Daniel de la Cadena, María Páez Cordero, Oscar Javier Nogueira, Montserrat Ayude, José Fernández-Briera, Almudena Rodríguez-Berrocal, Francisco Javier Dis Markers Other The purpose of this study was to assess if the combination of CD26 and alpha-L-fucosidase has a role in the diagnosis of colorectal cancer, paying particular attention to the stages in which the tumour is not yet disseminated. CD26 concentration and alpha-L-fucosidase activity were determined in sera from 110 colorectal cancer patients and 46 donors. The combination of CD26 and alpha-L-fucosidase showed a specificity of 100% with a sensitivity of 64% in the diagnosis of colorectal cancer. Interestingly, the combination of both markers had a sensitivity of 75% in the stage I at the highest specificity (100%), providing also high sensitivity levels for the other non-disseminated stages (66% for stages II and III). In conclusion, the combined use of CD26 and alpha-L-fucosidase offers high sensitivity with high specificity in the diagnosis of colorectal cancer, especially at the earliest stage (TNM I). IOS Press 2004 2004-07-14 /pmc/articles/PMC3851403/ /pubmed/15258327 http://dx.doi.org/10.1155/2004/834309 Text en Copyright © 2004 Hindawi Publishing Corporation.
spellingShingle Other
Ayude, Daniel
de la Cadena, María Páez
Cordero, Oscar Javier
Nogueira, Montserrat
Ayude, José
Fernández-Briera, Almudena
Rodríguez-Berrocal, Francisco Javier
Clinical Interest of the Combined Use of Serum CD26 and Alpha-L-Fucosidase in the Early Diagnosis of Colorectal Cancer
title Clinical Interest of the Combined Use of Serum CD26 and Alpha-L-Fucosidase in the Early Diagnosis of Colorectal Cancer
title_full Clinical Interest of the Combined Use of Serum CD26 and Alpha-L-Fucosidase in the Early Diagnosis of Colorectal Cancer
title_fullStr Clinical Interest of the Combined Use of Serum CD26 and Alpha-L-Fucosidase in the Early Diagnosis of Colorectal Cancer
title_full_unstemmed Clinical Interest of the Combined Use of Serum CD26 and Alpha-L-Fucosidase in the Early Diagnosis of Colorectal Cancer
title_short Clinical Interest of the Combined Use of Serum CD26 and Alpha-L-Fucosidase in the Early Diagnosis of Colorectal Cancer
title_sort clinical interest of the combined use of serum cd26 and alpha-l-fucosidase in the early diagnosis of colorectal cancer
topic Other
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851403/
https://www.ncbi.nlm.nih.gov/pubmed/15258327
http://dx.doi.org/10.1155/2004/834309
work_keys_str_mv AT ayudedaniel clinicalinterestofthecombineduseofserumcd26andalphalfucosidaseintheearlydiagnosisofcolorectalcancer
AT delacadenamariapaez clinicalinterestofthecombineduseofserumcd26andalphalfucosidaseintheearlydiagnosisofcolorectalcancer
AT corderooscarjavier clinicalinterestofthecombineduseofserumcd26andalphalfucosidaseintheearlydiagnosisofcolorectalcancer
AT nogueiramontserrat clinicalinterestofthecombineduseofserumcd26andalphalfucosidaseintheearlydiagnosisofcolorectalcancer
AT ayudejose clinicalinterestofthecombineduseofserumcd26andalphalfucosidaseintheearlydiagnosisofcolorectalcancer
AT fernandezbrieraalmudena clinicalinterestofthecombineduseofserumcd26andalphalfucosidaseintheearlydiagnosisofcolorectalcancer
AT rodriguezberrocalfranciscojavier clinicalinterestofthecombineduseofserumcd26andalphalfucosidaseintheearlydiagnosisofcolorectalcancer

Ejemplares similares